Siemens Healthineers Gestione

Gestione criteri di controllo 4/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Bernd Montag

Amministratore delegato

€5.7m

Compenso totale

Percentuale dello stipendio del CEO	24.1%
Mandato del CEO	9.8yrs
Proprietà del CEO	n/a
Durata media del management	3.8yrs
Durata media del Consiglio di amministrazione	4.2yrs

Aggiornamenti recenti sulla gestione

Recent updates

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Bernd Montag rispetto agli utili di Siemens Healthineers?
Data	Compenso totale	Stipendio	Guadagni aziendali
Sep 30 2024	n/a	n/a	€2b
Jun 30 2024	n/a	n/a	€2b
Mar 31 2024	n/a	n/a	€2b
Dec 31 2023	n/a	n/a	€2b
Sep 30 2023	€6m	€1m	€2b
Jun 30 2023	n/a	n/a	€2b
Mar 31 2023	n/a	n/a	€2b
Dec 31 2022	n/a	n/a	€2b
Sep 30 2022	€6m	€1m	€2b
Jun 30 2022	n/a	n/a	€2b
Mar 31 2022	n/a	n/a	€2b
Dec 31 2021	n/a	n/a	€2b
Sep 30 2021	€5m	€1m	€2b
Jun 30 2021	n/a	n/a	€2b
Mar 31 2021	n/a	n/a	€2b
Dec 31 2020	n/a	n/a	€2b
Sep 30 2020	€4m	€1m	€1b
Jun 30 2020	n/a	n/a	€1b
Mar 31 2020	n/a	n/a	€2b
Dec 31 2019	n/a	n/a	€2b
Sep 30 2019	€4m	€1m	€2b
Jun 30 2019	n/a	n/a	€1b
Mar 31 2019	n/a	n/a	€1b
Dec 31 2018	n/a	n/a	€1b
Sep 30 2018	€3m	€613k	€1b

Compensazione vs Mercato: La retribuzione totale di Bernd ($USD 6.02M ) è circa la media per le aziende di dimensioni simili nel mercato Swiss ($USD 4.76M ).

Compensazione vs guadagni: La retribuzione di Bernd è stata coerente con le performance aziendali dell'ultimo anno.

AMMINISTRATORE DELEGATO

Bernd Montag (55 yo)

9.8yrs

Mandato

€5,717,000

Compensazione

Dr. Bernhard Montag, also known as Bernd, serves as President and at Chairman of Management Board at Siemens Healthineers AG. He has been Chief Executive Officer at Siemens Healthineers AG since 2015 and s...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Bernhard Montag	President	9.8yrs	€5.72m	Nessun dato
Jochen Schmitz	CFO & Member of Management Board	6.9yrs	€2.94m	Nessun dato
Darleen Caron	Chief Human Resources Officer	3.8yrs	€2.56m	Nessun dato
Elisabeth Staudinger-Leibrecht	Member of Management Board	2.9yrs	€2.47m	Nessun dato
Marc Koebernick	Head of Investor Relations	no data	Nessun dato	Nessun dato
Christian Klaussner	Executive Vice President of Finance	no data	Nessun dato	Nessun dato
Andre Hartung	Head of Imaging	3.8yrs	Nessun dato	Nessun dato
Carsten Bertram	Head of Advanced Therapies	3.8yrs	Nessun dato	Nessun dato
David Pacitti	Head of Americas	3.8yrs	Nessun dato	Nessun dato
Sharon Bracken	Head of Diagnostics	2.5yrs	Nessun dato	Nessun dato
Jerry Wang	Head of China	2.8yrs	Nessun dato	Nessun dato
Vy Tran	Head of Asia Pacific Japan	2.8yrs	Nessun dato	Nessun dato

3.8yrs

Durata media

55yo

Età media

Gestione esperta: Il team dirigenziale di SHL è considerato esperto (durata media dell'incarico 3.8 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Peer Schatz	Independent Member of Supervisory Board	3.7yrs	€229.67k	Nessun dato
Dow Wilson	Independent Member of Supervisory Board	1.8yrs	€133.08k	Nessun dato
Karl-Heinz Streibich	Independent Deputy Chairman of Supervisory Board	6.7yrs	€238.75k	Nessun dato
Ralf Peter Thomas	Chairman of Supervisory Board	6.7yrs	Nessun dato	Nessun dato
Marion Helmes	Independent Member of Supervisory Board	6.7yrs	€248.83k	Nessun dato
Roland Busch	Member of Supervisory Board	4.8yrs	Nessun dato	Nessun dato
Sarena Lin	Independent Member of Supervisory Board	1.8yrs	€118.83k	Nessun dato
Nathalie von Siemens	Independent Member of Supervisory Board	6.7yrs	€161.75k	Nessun dato
Veronika Bienert	Member of Supervisory Board	1.8yrs	€132.33k	Nessun dato
Peter Korte	Member of Supervisory Board	1.8yrs	€151.00k	Nessun dato

4.2yrs

Durata media

59yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di SHL sono considerati esperti (durata media dell'incarico 4.2 anni).

Siemens Healthineers Gestione

Gestione criteri di controllo 4/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Siemens Healthineers AG Appoints Vivek Kanade as Head of Middle East and Africa

Siemens Healthineers AG Appoints Vivek Kanade as Head of Middle East and Africa

Siemens Healthineers AG, Annual General Meeting, Apr 18, 2024

Siemens Healthineers AG, Annual General Meeting, Feb 15, 2023

Recent updates

Full year 2024 earnings released: EPS: €1.74 (vs €1.35 in FY 2023)

Siemens Healthineers AG to Report Fiscal Year 2024 Results on Nov 26, 2024

Siemens Healthineers Offers to Buy Novartis Molecular Imaging Business

Third quarter 2024 earnings released: EPS: €0.42 (vs €0.40 in 3Q 2023)

Second quarter 2024 earnings released: EPS: €0.38 (vs €0.09 in 2Q 2023)

Upcoming dividend of €0.95 per share

First quarter 2024 earnings released: EPS: €0.39 (vs €0.38 in 1Q 2023)

Siemens Healthineers AG Appoints Vivek Kanade as Head of Middle East and Africa

Siemens Healthineers AG Appoints Vivek Kanade as Head of Middle East and Africa

Full year 2023 earnings released: EPS: €1.35 (vs €1.82 in FY 2022)

Investor sentiment improves as stock rises 15%

Siemens Healthineers AG, Annual General Meeting, Apr 18, 2024

Siemens Healthineers AG to Report Fiscal Year 2023 Final Results on Nov 27, 2023

Siemens Healthineers AG to Report Q2, 2024 Results on May 06, 2024

Siemens Healthineers AG to Report Q1, 2024 Results on Feb 01, 2024

Third quarter 2023 earnings released: EPS: €0.40 (vs €0.32 in 3Q 2022)

Second quarter 2023 earnings released: EPS: €0.093 (vs €0.52 in 2Q 2022)

Upcoming dividend of €0.95 per share at 1.8% yield

First quarter 2023 earnings released: EPS: €0.38 (vs €0.41 in 1Q 2022)

Siemens Healthineers AG to Report Q1, 2023 Results on Feb 02, 2023

Siemens Healthineers, GE Healthcare Studying Potential Deals with Medtronic's Spun Off Units

Siemens Healthineers AG to Report Q2, 2023 Results on May 10, 2023

Siemens Healthineers AG, Annual General Meeting, Feb 15, 2023

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Second quarter 2022 earnings released: EPS: €0.52 (vs €0.41 in 2Q 2021)

Upcoming dividend of €0.85 per share

First quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Siemens Healthineers Launches Enhanced Liver Fibrosis (ELF) Test in the U.S

Siemens Healthineers Announces FDA Emergency Use Authorization For CLINITEST® Rapid COVID-19 Antigen Self-Test

Full year 2021 earnings released: EPS €1.57 (vs €1.41 in FY 2020)

FDA Grants Marketing Authorization to Siemens Healthineers's ELF Test for NASH Prognostic Assessment

Second quarter 2021 earnings released: EPS €0.41 (vs €0.41 in 2Q 2020)

Upcoming Dividend of €0.80 Per Share

New 90-day high: CHF46.20

Renown Institute for Health Innovation Expands Partnership with Gilead Sciences, Inc. and Siemens Healthineers to Offer ELF- Enhanced Liver Fibrosis Testing for Nevada Nash Study Participants

Siemens Healthineers AG to Report Q1, 2021 Results on Feb 01, 2021

Full year 2020 earnings released: EPS €1.41

Revenue misses expectations

Revenue misses expectations

Full year 2020 earnings released: EPS €1.41

Siemens Healthineers and University of Iowa Health Care Team Up to Advance Care for Iowans Over the Next Decade

Siemens Healthineers and WakeMed Health & Hospitals Announce Innovative Relationship to Advance Care and Improve Outcomes

Siemens Healthineers Announces Collaboration Agreement for Assay Development with an Initial Focus on Multiple Sclerosis

Siemens Healthineers AG has completed a Follow-on Equity Offering in the amount of €2.73 billion.

Earnings released

Analisi delle retribuzioni degli amministratori delegati

AMMINISTRATORE DELEGATO

Mandato

Compensazione

Gruppo dirigente

Durata media

Età media

Membri del Consiglio di amministrazione

Durata media

Età media